United States Patent Number 5,988,870
Rhinitis Medicamentosa (RM) is a form of chemically induced nasal congestion and swelling of the mucosa due to the prolonged use of decongestant nasal sprays. Rhinostat has focused on RM patients since 1999.
The Rhinostat System
Rhinostat is the only patented nasal spray product that is specifically designed for the treatment of Rhinitis Medicamentosa patients, to help overcome Afrin nasal spray addiction and other decongestants. Rhinostat facilitates comfortable airflow during the withdrawal process.
Safe, Effective, Guaranteed
Rhinostat works with physicians and directly with RM patients. Our kits are individually formulated and shipped within one business day. Rhinostat offers an unconditional money back guarantee. We ship worldwide.